BACKGROUND: Antipsychotic-induced metabolic syndrome (MetS) is a multifactorial disease with a genetic predisposition. Serotonin and its receptors are involved in antipsychotic-drug-induced metabolic disorders. The present study investigated the association of nine polymorphisms in the four 5-hydroxytryptamine receptor (HTR) genes HTR1A, HTR2A, HTR3A, and HTR2C and the gene encoding for the serotonin transporter SLC6A4 with MetS in patients with schizophrenia. METHODS: A set of nine single-nucleotide polymorphisms of genes of the serotonergic system was investigated in a population of 475 patients from several Siberian regions (Russia) with a clinical diagnosis of schizophrenia. Genotyping was performed and the results were analyzed using chi-square tests. RESULTS: Polymorphic variant rs521018 (HTR2C) was associated with higher body mass index in patients receiving long-term antipsychotic therapy, but not with drug-induced metabolic syndrome. Rs1150226 (HTR3A) was also associated but did not meet Hardy-Weinberg equilibrium. CONCLUSIONS: Our results indicate that allelic variants of HTR2C genes may have consequences on metabolic parameters. MetS may have too complex a mechanistic background to be studied without dissecting the syndrome into its individual (causal) components.
BACKGROUND: Antipsychotic-induced metabolic syndrome (MetS) is a multifactorial disease with a genetic predisposition. Serotonin and its receptors are involved in antipsychotic-drug-induced metabolic disorders. The present study investigated the association of nine polymorphisms in the four 5-hydroxytryptamine receptor (HTR) genes HTR1A, HTR2A, HTR3A, and HTR2C and the gene encoding for the serotonin transporter SLC6A4 with MetS in patients with schizophrenia. METHODS: A set of nine single-nucleotide polymorphisms of genes of the serotonergic system was investigated in a population of 475 patients from several Siberian regions (Russia) with a clinical diagnosis of schizophrenia. Genotyping was performed and the results were analyzed using chi-square tests. RESULTS: Polymorphic variant rs521018 (HTR2C) was associated with higher body mass index in patients receiving long-term antipsychotic therapy, but not with drug-induced metabolic syndrome. Rs1150226 (HTR3A) was also associated but did not meet Hardy-Weinberg equilibrium. CONCLUSIONS: Our results indicate that allelic variants of HTR2C genes may have consequences on metabolic parameters. MetS may have too complex a mechanistic background to be studied without dissecting the syndrome into its individual (causal) components.
Entities:
Keywords:
antipsychotics; body mass index; genes; metabolic syndrome; pharmacogenetics; schizophrenia; serotonin; weight gain
Authors: Carolin Opgen-Rhein; Eva Janina Brandl; Daniel J Müller; Andres H Neuhaus; Arun K Tiwari; Thomas Sander; Michael Dettling Journal: Pharmacogenomics Date: 2010-06 Impact factor: 2.533
Authors: Ivan V Pozhidaev; Diana Z Paderina; Olga Yu Fedorenko; Elena G Kornetova; Arkadiy V Semke; Anton J M Loonen; Nikolay A Bokhan; Bob Wilffert; Svetlana A Ivanova Journal: Front Mol Neurosci Date: 2020-04-24 Impact factor: 5.639
Authors: Anastasiia S Boiko; Ivan V Pozhidaev; Diana Z Paderina; Irina A Mednova; Anastasya A Goncharova; Olga Yu Fedorenko; Elena G Kornetova; Arkadiy V Semke; Nikolay A Bokhan; Anton J M Loonen; Svetlana A Ivanova Journal: Genes (Basel) Date: 2022-05-08 Impact factor: 4.141
Authors: Anastasiia S Boiko; Ivan V Pozhidaev; Diana Z Paderina; Anna V Bocharova; Irina A Mednova; Olga Yu Fedorenko; Elena G Kornetova; Anton J M Loonen; Arkadiy V Semke; Nikolay A Bokhan; Svetlana A Ivanova Journal: Pharmgenomics Pers Med Date: 2021-09-07
Authors: Diana Z Paderina; Anastasiia S Boiko; Ivan V Pozhidaev; Irina A Mednova; Anastasia A Goncharova; Anna V Bocharova; Olga Yu Fedorenko; Elena G Kornetova; Arkadiy V Semke; Nikolay A Bokhan; Anton J M Loonen; Svetlana A Ivanova Journal: Genes (Basel) Date: 2022-07-23 Impact factor: 4.141